| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.451 | 0.008 | 0.451 | Cholinergic | 0.247 0.03 CID_154699806 0.364 0.012 CID_154699786 | ||
| 0.466 | 0.038 | 0.684 | Aldehyde oxidase inhibitor | 0.243 0.085 CID_154699806 0.684 0.009 CID_154699786 | CID_154699786 | |
| 0.386 | 0.004 | 0.386 | Acetylcholine M4 receptor antagonist | 0.214 0.005 CID_154699806 0.162 0.009 CID_154699786 | ||
| 0.375 | 0.007 | 0.375 | Butyrylcholinesterase inhibitor | 0.117 0.049 CID_154699806 0.265 0.013 CID_154699786 | ||
| 0.365 | 0.009 | 0.365 | Cholinergic antagonist | 0.229 0.025 CID_154699806 0.293 0.015 CID_154699786 | ||
| 0.442 | 0.087 | 0.54 | Caspase 9 stimulant | 0.54 0.047 CID_154699786 | CID_154699786 | |
| 0.388 | 0.042 | 0.388 | Spasmolytic | 0.22 0.105 CID_154699806 0.386 0.043 CID_154699786 | ||
| 0.347 | 0.006 | 0.347 | Acetylcholine muscarinic antagonist | 0.248 0.015 CID_154699806 0.294 0.009 CID_154699786 | ||
| 0.348 | 0.01 | 0.348 | Acetylcholine antagonist | 0.222 0.026 CID_154699806 0.277 0.016 CID_154699786 | ||
| 0.334 | 0.007 | 0.334 | Alpha 2b adrenoreceptor antagonist | 0.158 0.036 CID_154699806 0.274 0.011 CID_154699786 | ||
| 0.331 | 0.005 | 0.418 | Histamine H1 receptor antagonist | 0.418 0.004 CID_154699806 0.21 0.013 CID_154699786 | CID_154699806 | |
| 0.346 | 0.037 | 0.346 | Potassium channel (Voltage-sensitive) blocker | 0.266 0.06 CID_154699806 | ||
| 0.334 | 0.041 | 0.334 | HERG channel blocker | 0.26 0.062 CID_154699806 | ||
| 0.305 | 0.014 | 0.305 | Acetylcholine M1 receptor antagonist | 0.203 0.041 CID_154699806 0.268 0.021 CID_154699786 | ||
| 0.386 | 0.114 | 0.386 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.331 0.173 CID_154699806 | ||
| 0.249 | 0.016 | 0.249 | 5 Hydroxytryptamine 3E antagonist | 0.232 0.026 CID_154699806 0.192 0.078 CID_154699786 | ||
| 0.227 | 0.005 | 0.227 | 5 Hydroxytryptamine 3 antagonist | 0.072 0.028 CID_154699806 0.071 0.028 CID_154699786 | ||
| 0.246 | 0.025 | 0.246 | 5 Hydroxytryptamine antagonist | 0.093 0.086 CID_154699806 0.126 0.061 CID_154699786 | ||
| 0.274 | 0.054 | 0.274 | Gastrin inhibitor | 0.248 0.081 CID_154699806 0.198 0.151 CID_154699786 | ||
| 0.231 | 0.016 | 0.3 | Antihistaminic | 0.3 0.01 CID_154699806 0.096 0.058 CID_154699786 | CID_154699806 | |
| 0.222 | 0.016 | 0.264 | Histamine antagonist | 0.264 0.012 CID_154699806 0.083 0.061 CID_154699786 | CID_154699806 | |
| 0.259 | 0.059 | 0.294 | Cyclic AMP phosphodiesterase inhibitor | 0.294 0.044 CID_154699786 | CID_154699786 | |
| 0.19 | 0.005 | 0.19 | Acetylcholine M5 receptor antagonist | 0.101 0.017 CID_154699806 0.133 0.01 CID_154699786 | ||
| 0.219 | 0.037 | 0.306 | Antipruritic | 0.306 0.013 CID_154699806 0.171 0.072 CID_154699786 | CID_154699806 | |
| 0.209 | 0.03 | 0.209 | Anesthetic local | 0.148 0.05 CID_154699786 | ||
| 0.197 | 0.019 | 0.197 | Alpha 2c adrenoreceptor antagonist | 0.16 0.028 CID_154699786 | ||
| 0.192 | 0.022 | 0.192 | Nav1.6 sodium channel blocker | 0.17 0.035 CID_154699786 | ||
| 0.19 | 0.021 | 0.19 | Nav1.1 sodium channel blocker | 0.189 0.021 CID_154699786 | ||
| 0.303 | 0.139 | 0.303 | Analgesic | 0.242 0.19 CID_154699786 | ||
| 0.195 | 0.032 | 0.195 | Calcium channel blocker | 0.181 0.039 CID_154699806 0.122 0.086 CID_154699786 | ||
| 0.167 | 0.005 | 0.167 | Cholecystokinin antagonist | 0.11 0.007 CID_154699806 0.063 0.017 CID_154699786 | ||
| 0.163 | 0.004 | 0.163 | 5 Hydroxytryptamine 3A antagonist | 0.091 0.022 CID_154699806 0.09 0.023 CID_154699786 | ||
| 0.281 | 0.129 | 0.281 | GABA C receptor rho-3 antagonist | 0.215 0.189 CID_154699806 0.281 0.129 CID_154699786 | ||
| 0.255 | 0.104 | 0.255 | Nootropic | |||
| 0.166 | 0.016 | 0.166 | Ca2+-transporting ATPase inhibitor | 0.138 0.08 CID_154699806 0.159 0.025 CID_154699786 | ||
| 0.236 | 0.09 | 0.236 | 5 Hydroxytryptamine 1E antagonist | 0.2 0.131 CID_154699786 | ||
| 0.239 | 0.094 | 0.261 | 5 Hydroxytryptamine release stimulant | 0.261 0.084 CID_154699806 0.21 0.113 CID_154699786 | CID_154699806 | |
| 0.167 | 0.023 | 0.167 | Alpha 2 adrenoreceptor antagonist | 0.134 0.032 CID_154699786 | ||
| 0.22 | 0.081 | 0.279 | Potassium channel blocker | 0.279 0.054 CID_154699806 | CID_154699806 | |
| 0.154 | 0.025 | 0.154 | Acetylcholine agonist | |||
| 0.124 | 0.005 | 0.124 | Cholecystokinin B antagonist | 0.078 0.005 CID_154699806 0.039 0.015 CID_154699786 | ||
| 0.133 | 0.014 | 0.133 | Acetylcholine M2 receptor antagonist | 0.087 0.026 CID_154699806 0.092 0.024 CID_154699786 | ||
| 0.142 | 0.022 | 0.142 | Acetylcholine release stimulant | 0.115 0.056 CID_154699806 0.102 0.084 CID_154699786 | ||
| 0.142 | 0.023 | 0.142 | Acetylcholine nicotinic antagonist | 0.096 0.042 CID_154699786 | ||
| 0.155 | 0.036 | 0.155 | Alpha adrenoreceptor antagonist | 0.105 0.054 CID_154699786 | ||
| 0.224 | 0.107 | 0.224 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.121 | 0.008 | 0.121 | 5 Hydroxytryptamine 3 agonist | 0.062 0.046 CID_154699806 0.087 0.022 CID_154699786 | ||
| 0.224 | 0.112 | 0.224 | 5 Hydroxytryptamine uptake stimulant | 0.202 0.147 CID_154699786 | ||
| 0.247 | 0.138 | 0.258 | Vasodilator, coronary | 0.258 0.126 CID_154699786 | CID_154699786 | |
| 0.12 | 0.014 | 0.12 | Acetylcholine M3 receptor antagonist | 0.059 0.043 CID_154699806 0.118 0.015 CID_154699786 | ||
| 0.156 | 0.053 | 0.164 | Adenylate cyclase stimulant | 0.164 0.042 CID_154699786 | CID_154699786 | |
| 0.117 | 0.014 | 0.117 | Acetylcholine muscarinic agonist | 0.062 0.032 CID_154699806 | ||
| 0.141 | 0.04 | 0.141 | 5 Hydroxytryptamine 3A agonist | 0.09 0.088 CID_154699806 0.103 0.073 CID_154699786 | ||
| 0.151 | 0.053 | 0.248 | NADPH oxidase inhibitor | 0.248 0.021 CID_154699786 | CID_154699786 | |
| 0.127 | 0.031 | 0.127 | Acetylcholine M3 receptor agonist | 0.085 0.056 CID_154699806 | ||
| 0.212 | 0.116 | 0.248 | Tyrosine 3 hydroxylase inhibitor | 0.194 0.147 CID_154699806 0.248 0.07 CID_154699786 | CID_154699786 | |
| 0.134 | 0.039 | 0.134 | Transcription factor STAT6 inhibitor | 0.129 0.046 CID_154699786 | ||
| 0.118 | 0.024 | 0.118 | 5 Hydroxytryptamine 1F antagonist | 0.062 0.057 CID_154699786 | ||
| 0.147 | 0.054 | 0.15 | Heat shock protein 70 antagonist | 0.15 0.045 CID_154699786 | CID_154699786 | |
| 0.109 | 0.016 | 0.109 | Toll-Like receptor 7 antagonist | 0.076 0.041 CID_154699806 | ||
| 0.107 | 0.015 | 0.107 | Sigma receptor antagonist | 0.059 0.029 CID_154699806 0.058 0.029 CID_154699786 | ||
| 0.103 | 0.012 | 0.103 | Acetylcholine M1 receptor agonist | 0.05 0.025 CID_154699806 | ||
| 0.118 | 0.031 | 0.118 | Histamine N-methyltransferase inhibitor | 0.098 0.048 CID_154699786 | ||
| 0.099 | 0.019 | 0.099 | Adrenaline uptake inhibitor | 0.063 0.042 CID_154699786 | ||
| 0.086 | 0.011 | 0.086 | Acetylcholine M2 receptor agonist | 0.061 0.028 CID_154699806 0.059 0.03 CID_154699786 | ||
| 0.128 | 0.053 | 0.128 | 5 Hydroxytryptamine 2B antagonist | 0.102 0.081 CID_154699786 | ||
| 0.213 | 0.138 | 0.213 | Insulysin inhibitor | 0.208 0.145 CID_154699786 | ||
| 0.24 | 0.166 | 0.24 | Antiobesity | |||
| 0.105 | 0.031 | 0.138 | Opioid kappa receptor antagonist | 0.074 0.068 CID_154699806 0.138 0.019 CID_154699786 | CID_154699786 | |
| 0.236 | 0.166 | 0.264 | Histamine release inhibitor | 0.264 0.145 CID_154699786 | CID_154699786 | |
| 0.103 | 0.034 | 0.103 | Alpha 1b adrenoreceptor antagonist | 0.074 0.05 CID_154699786 | ||
| 0.233 | 0.167 | 0.242 | Calcium channel activator | 0.208 0.202 CID_154699806 0.242 0.156 CID_154699786 | CID_154699786 | |
| 0.171 | 0.106 | 0.188 | Anticonvulsant | 0.188 0.092 CID_154699806 | CID_154699806 | |
| 0.129 | 0.065 | 0.129 | Nav1.3 sodium channel blocker | |||
| 0.111 | 0.051 | 0.111 | Gastric antisecretory | 0.098 0.068 CID_154699806 | ||
| 0.084 | 0.024 | 0.084 | Dopamine uptake inhibitor | 0.054 0.044 CID_154699786 | ||
| 0.11 | 0.05 | 0.11 | Antiadrenergic | 0.084 0.067 CID_154699786 | ||
| 0.096 | 0.038 | 0.096 | Alpha 2a adrenoreceptor antagonist | 0.089 0.042 CID_154699786 | ||
| 0.097 | 0.04 | 0.097 | Dopamine antagonist | 0.084 0.045 CID_154699806 0.076 0.05 CID_154699786 | ||
| 0.128 | 0.071 | 0.128 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.075 | 0.019 | 0.075 | Nicotinic receptor alpha7 subunit antagonist | 0.054 0.036 CID_154699786 | ||
| 0.063 | 0.009 | 0.063 | Acetylcholine M4 receptor agonist | |||
| 0.105 | 0.051 | 0.105 | Adrenaline antagonist | 0.08 0.068 CID_154699786 | ||
| 0.103 | 0.051 | 0.103 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.121 | 0.069 | 0.124 | DNA repair enzyme inhibitor | 0.124 0.064 CID_154699786 | CID_154699786 | |
| 0.083 | 0.032 | 0.119 | Dopamine D1 antagonist | 0.119 0.02 CID_154699786 | CID_154699786 | |
| 0.114 | 0.065 | 0.114 | Photosensitizer | 0.104 0.081 CID_154699786 | ||
| 0.132 | 0.084 | 0.132 | Cell wall synthesis inhibitor | 0.117 0.104 CID_154699806 0.132 0.084 CID_154699786 | ||
| 0.068 | 0.021 | 0.068 | Dopamine transporter inhibitor | |||
| 0.155 | 0.112 | 0.155 | Psychostimulant | 0.153 0.113 CID_154699806 | ||
| 0.109 | 0.066 | 0.109 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.095 | 0.052 | 0.132 | Opioid antagonist | 0.132 0.031 CID_154699786 | CID_154699786 | |
| 0.087 | 0.044 | 0.089 | CC chemokine 5 receptor agonist | 0.089 0.038 CID_154699786 | CID_154699786 | |
| 0.057 | 0.017 | 0.057 | Cholecystokinin A antagonist | 0.033 0.029 CID_154699806 | ||
| 0.146 | 0.107 | 0.146 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.112 | 0.075 | 0.112 | Calcium channel N-type blocker | 0.105 0.086 CID_154699806 | ||
| 0.078 | 0.041 | 0.078 | Calcium channel L-type blocker | |||
| 0.054 | 0.017 | 0.054 | Guanylate cyclase inhibitor | 0.039 0.035 CID_154699786 | ||
| 0.073 | 0.037 | 0.073 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.076 | 0.04 | 0.076 | Neuronal nicotinic receptor antagonist | |||
| 0.128 | 0.093 | 0.128 | Cytidine deaminase inhibitor | |||
| 0.046 | 0.011 | 0.046 | ATM kinase inhibitor | 0.035 0.029 CID_154699786 | ||
| 0.058 | 0.024 | 0.058 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.049 0.03 CID_154699806 | ||
| 0.076 | 0.042 | 0.114 | Opioid mu receptor antagonist | 0.114 0.027 CID_154699786 | CID_154699786 | |
| 0.089 | 0.057 | 0.089 | Ca(v)2.2 blocker | |||
| 0.098 | 0.069 | 0.098 | GABA C receptor agonist | |||
| 0.076 | 0.048 | 0.076 | Vanilloid 4 agonist | |||
| 0.108 | 0.079 | 0.108 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.196 | 0.169 | 0.284 | Cholesterol antagonist | 0.284 0.102 CID_154699786 | CID_154699786 | |
| 0.07 | 0.044 | 0.07 | Dopamine D2 antagonist | 0.07 0.044 CID_154699806 | ||
| 0.063 | 0.039 | 0.063 | Alpha 1d adrenoreceptor antagonist | |||
| 0.057 | 0.034 | 0.057 | Nicotinic alpha7 receptor agonist | |||
| 0.08 | 0.057 | 0.08 | Acetylcholine nicotinic agonist | |||
| 0.048 | 0.026 | 0.052 | Opioid kappa receptor agonist | 0.052 0.023 CID_154699786 | CID_154699786 | |
| 0.066 | 0.044 | 0.09 | Cannabinoid receptor agonist | 0.09 0.03 CID_154699806 | CID_154699806 | |
| 0.079 | 0.058 | 0.079 | Glycine receptor antagonist | |||
| 0.067 | 0.047 | 0.067 | Acetylcholine M5 receptor agonist | |||
| 0.079 | 0.06 | 0.079 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.074 | 0.056 | 0.074 | Alpha 1 adrenoreceptor antagonist | |||
| 0.07 | 0.053 | 0.07 | Phospholipase D inhibitor | |||
| 0.032 | 0.016 | 0.032 | Sigma 1 receptor antagonist | 0.026 0.019 CID_154699806 | ||
| 0.073 | 0.058 | 0.095 | Analgesic, opioid | 0.095 0.034 CID_154699786 | CID_154699786 | |
| 0.055 | 0.041 | 0.055 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.043 | 0.03 | 0.043 | Heme oxygenase inhibitor | |||
| 0.045 | 0.033 | 0.045 | Adenylate cyclase 1 inhibitor | |||
| 0.149 | 0.137 | 0.222 | Hypolipemic | 0.222 0.081 CID_154699786 | CID_154699786 | |
| 0.077 | 0.064 | 0.077 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.098 | 0.086 | 0.098 | Calcium channel (voltage-sensitive) blocker | |||
| 0.109 | 0.098 | 0.109 | Nav1.2 sodium channel blocker | |||
| 0.018 | 0.009 | 0.018 | NMDA receptor phencyclidine site antagonist | 0.017 0.009 CID_154699786 | ||
| 0.052 | 0.044 | 0.052 | Glucosylceramidase inhibitor | |||
| 0.085 | 0.079 | 0.085 | Sphingomyelinase inhibitor | |||
| 0.084 | 0.078 | 0.085 | Glutamate release inhibitor | 0.085 0.076 CID_154699786 | CID_154699786 | |
| 0.077 | 0.072 | 0.077 | Histamine H2 receptor antagonist | |||
| 0.049 | 0.046 | 0.049 | Nicotinic neuronal receptor agonist | |||
| 0.122 | 0.12 | 0.156 | Sphingosine 1-phosphate receptor 5 antagonist | 0.156 0.052 CID_154699806 0.123 0.118 CID_154699786 | CID_154699806 | |
| 0.048 | 0.046 | 0.093 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.093 0.012 CID_154699786 | CID_154699786 | |
| 0.058 | 0.058 | 0.208 | Leukotriene synthesis inhibitor | 0.208 0.005 CID_154699806 0.094 0.029 CID_154699786 | CID_154699806 | |
| 0.1 | 0.105 | 0.127 | Acetylcholinesterase inhibitor | 0.127 0.072 CID_154699786 | CID_154699786 | |
| 0.21 | 0.218 | 0.251 | Antibacterial | 0.251 0.176 CID_154699786 | CID_154699786 | |
| 0.055 | 0.065 | 0.061 | Phosphodiesterase 4B inhibitor | 0.061 0.055 CID_154699806 | CID_154699806 | |
| 0.052 | 0.071 | 0.07 | Lipase inhibitor | 0.07 0.054 CID_154699786 | CID_154699786 | |
| 0.074 | 0.093 | 0.086 | Prolactin inhibitor | 0.086 0.072 CID_154699786 | CID_154699786 | |
| 0.022 | 0.044 | 0.044 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.044 0.013 CID_154699786 | CID_154699786 | |
| 0.027 | 0.05 | 0.089 | Estradiol 17 beta-dehydrogenase inhibitor | 0.089 0.012 CID_154699786 | CID_154699786 | |
| 0.028 | 0.055 | 0.043 | Dopamine D5 agonist | 0.043 0.024 CID_154699786 | CID_154699786 | |
| 0.065 | 0.093 | 0.08 | Antineoplastic alkaloid | 0.08 0.065 CID_154699786 | CID_154699786 | |
| 0.127 | 0.17 | 0.14 | Neurotensin receptor agonist | 0.14 0.128 CID_154699786 | CID_154699786 | |
| 0.06 | 0.107 | 0.1 | Estrogen receptor alpha antagonist | 0.1 0.027 CID_154699786 | CID_154699786 | |
| 0.009 | 0.06 | 0.025 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.025 0.014 CID_154699786 | CID_154699786 | |
| 0.085 | 0.137 | 0.257 | Estrogen antagonist | 0.257 0.008 CID_154699786 | CID_154699786 | |
| 0.063 | 0.116 | 0.076 | MAP kinase kinase 7 inhibitor | 0.076 0.058 CID_154699786 | CID_154699786 | |
| 0.136 | 0.189 | 0.15 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.15 0.149 CID_154699786 | CID_154699786 | |
| 0.074 | 0.128 | 0.095 | Beta glucuronidase inhibitor | 0.095 0.078 CID_154699786 | CID_154699786 | |
| 0.126 | 0.18 | 0.204 | Antiamyloidogenic | 0.204 0.097 CID_154699786 | CID_154699786 | |
| 0.03 | 0.09 | 0.057 | Cannabinoid CB1 receptor agonist | 0.057 0.045 CID_154699806 | CID_154699806 | |
| 0.014 | 0.076 | 0.069 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.069 0.009 CID_154699786 | CID_154699786 | |
| 0.102 | 0.176 | 0.147 | Amyloid beta precursor protein antagonist | 0.147 0.105 CID_154699786 | CID_154699786 | |
| 0.044 | 0.125 | 0.081 | Telomerase inhibitor | 0.081 0.044 CID_154699806 | CID_154699806 | |
| 0.056 | 0.144 | 0.095 | Creatine kinase inhibitor | 0.095 0.066 CID_154699786 | CID_154699786 | |
| 0.024 | 0.116 | 0.058 | Opioid delta receptor antagonist | 0.058 0.048 CID_154699786 | CID_154699786 | |
| 0.06 | 0.154 | 0.231 | Estrogen receptor beta antagonist | 0.231 0.008 CID_154699786 | CID_154699786 | |
| 0.14 | 0.238 | 0.196 | Hypoxia-inducible factor 1 alpha inhibitor | 0.196 0.156 CID_154699786 | CID_154699786 | |
| 0.018 | 0.123 | 0.044 | Benzodiazepine receptor peripheral-type antagonist | 0.044 0.01 CID_154699806 | CID_154699806 | |
| 0.018 | 0.14 | 0.051 | Prostaglandin EP2 antagonist | 0.051 0.05 CID_154699786 | CID_154699786 | |
| 0.073 | 0.205 | 0.217 | Amyloid beta aggregation inhibitor | 0.217 0.069 CID_154699786 | CID_154699786 | |
| 0.019 | 0.156 | 0.051 | Plasminogen activator inhibitor antagonist | 0.051 0.031 CID_154699786 | CID_154699786 | |
| 0.008 | 0.18 | 0.108 | Estrogen agonist | 0.108 0.015 CID_154699786 | CID_154699786 | |
| 0.016 | 0.205 | 0.053 | CC chemokine 5 receptor antagonist | 0.053 0.033 CID_154699806 | CID_154699806 | |
| 0.123 | 0.312 | 0.22 | 15-Lipoxygenase inhibitor | 0.22 0.191 CID_154699786 | CID_154699786 | |
| 0.03 | 0.23 | 0.087 | Topoisomerase I inhibitor | 0.087 0.082 CID_154699786 | CID_154699786 | |
| 0.004 | 0.21 | 0.081 | Estrogen receptor beta agonist | 0.081 0.014 CID_154699786 | CID_154699786 | |
| 0.033 | 0.262 | 0.1 | Topoisomerase II inhibitor | 0.1 0.086 CID_154699786 | CID_154699786 | |
| 0.007 | 0.239 | 0.119 | Beta tubulin antagonist | 0.119 0.018 CID_154699806 | CID_154699806 | |
| 0.003 | 0.242 | 0.066 | Estrogen receptor alpha agonist | 0.066 0.014 CID_154699786 | CID_154699786 | |
| 0.038 | 0.309 | 0.113 | Lipid peroxidase inhibitor | 0.113 0.101 CID_154699786 | CID_154699786 | |
| 0.104 | 0.416 | 0.197 | Caspase 3 stimulant | 0.197 0.174 CID_154699786 | CID_154699786 | |
| 0.044 | 0.447 | 0.231 | Tumour necrosis factor alpha release inhibitor | 0.231 0.085 CID_154699806 | CID_154699806 | |
| 0.028 | 0.543 | 0.242 | Interleukin 1 antagonist | 0.242 0.02 CID_154699806 | CID_154699806 | |
| 0.038 | 0.593 | 0.126 | NOS3 expression enhancer | 0.126 0.105 CID_154699786 | CID_154699786 | |
| 0.046 | 0.674 | 0.294 | Sodium/bile acid cotransporter inhibitor | 0.294 0.085 CID_154699786 | CID_154699786 | |
| 0.022 | 0.668 | 0.252 | Interleukin 1b antagonist | 0.252 0.012 CID_154699806 | CID_154699806 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |